Campbell AK - Search Results

1

The ninth complement component in rheumatoid arthritis, Behçet's disease and other rheumatic diseases.

Rumfeld WR, Morgan BP, Campbell AK. Rumfeld WR, et al. Among authors: campbell ak. Br J Rheumatol. 1986 Aug;25(3):266-70. doi: 10.1093/rheumatology/25.3.266. Br J Rheumatol. 1986. PMID: 3488089

2

Complement component C9 in Graves' disease.

Oleesky DA, Ratanachaiyavong S, Ludgate M, Morgan BP, Campbell AK, McGregor AM. Oleesky DA, et al. Among authors: campbell ak. Clin Endocrinol (Oxf). 1986 Dec;25(6):623-32. doi: 10.1111/j.1365-2265.1986.tb03617.x. Clin Endocrinol (Oxf). 1986. PMID: 3308182

3

Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis.

Morgan BP, Campbell AK, Compston DA. Morgan BP, et al. Among authors: campbell ak. Lancet. 1984 Aug 4;2(8397):251-4. doi: 10.1016/s0140-6736(84)90298-8. Lancet. 1984. PMID: 6146808

4

Immunoradiometric assay for human complement component C9 utilising monoclonal antibodies.

Morgan BP, Campbell AK, Luzio JP, Siddle K. Morgan BP, et al. Among authors: campbell ak. Clin Chim Acta. 1983 Oct 31;134(1-2):85-94. doi: 10.1016/0009-8981(83)90187-0. Clin Chim Acta. 1983. PMID: 6652914

5

Cerebrospinal fluid C9 in demyelinating disease.

Compston DA, Morgan BP, Oleesky D, Fifield R, Campbell AK. Compston DA, et al. Among authors: campbell ak. Neurology. 1986 Nov;36(11):1503-6. doi: 10.1212/wnl.36.11.1503. Neurology. 1986. PMID: 3762967

6

Monoclonal antibodies demonstrate protection of polymorphonuclear leukocytes against complement attack.

Campbell AK, Morgan BP. Campbell AK, et al. Nature. 1985 Sep 12-18;317(6033):164-6. doi: 10.1038/317164a0. Nature. 1985. PMID: 4033797

7

Immunoaffinity purification of human complement component C9 using monoclonal antibodies.

Morgan BP, Daw RA, Siddle K, Luzio JP, Campbell AK. Morgan BP, et al. Among authors: campbell ak. J Immunol Methods. 1983 Nov 25;64(3):269-81. doi: 10.1016/0022-1759(83)90434-9. J Immunol Methods. 1983. PMID: 6199425

8

Immunolocalization of complement component C9 on necrotic and non-necrotic muscle fibres in myositis using monoclonal antibodies: a primary role of complement in autoimmune cell damage.

Morgan BP, Sewry CA, Siddle K, Luzio JP, Campbell AK. Morgan BP, et al. Among authors: campbell ak. Immunology. 1984 May;52(1):181-8. Immunology. 1984. PMID: 6370840 Free PMC article.

9

Inhibition of complement-induced [14C]sucrose release by intracellular and extracellular monoclonal antibodies to C9: evidence that C9 is a transmembrane protein.

Morgan BP, Luzio JP, Campbell AK. Morgan BP, et al. Among authors: campbell ak. Biochem Biophys Res Commun. 1984 Jan 30;118(2):616-22. doi: 10.1016/0006-291x(84)91347-0. Biochem Biophys Res Commun. 1984. PMID: 6704099

10

Altered glycosylation and selected mutation in recombinant human complement component C9: effects on haemolytic activity.

Taylor KM, Morgan BP, Campbell AK. Taylor KM, et al. Among authors: campbell ak. Immunology. 1994 Nov;83(3):501-6. Immunology. 1994. PMID: 7835977 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page